State Of Wyoming Novavax Inc Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $19,031 - $41,233	3,304 New	3,304 $22,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $28,951 - $60,081	-798 Reduced 99.5%	4 $0
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $55,505 - $113,748	796 Added 13266.67%	802 $58,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $269 - $435	-2 Reduced 25.0%	6 $1,000
Q3 2021 Feb 11, 2022	SELL	$177.8 - $270.58 $889 - $1,352	-5 Reduced 38.46%	8 $2,000
Q2 2021 Feb 11, 2022	BUY	$121.0 - $257.67 $726 - $1,546	6 Added 85.71%	13 $3,000
Q1 2021 Feb 08, 2022	BUY	$112.98 - $319.93 $790 - $2,239	7 New	7 $1,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.